Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs MTCH✓SelectedUSD · MTCHGSK vs MTCH performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs MTCH

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.3%
MTCH return
+139.1%
Excess return
-41.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMTCHExcessAlpha
1D-1.6%-1.2%-0.4%-1.5%
7D-4.7%-6.3%+1.6%-4.2%
30D-4.7%-15.9%+11.2%-3.4%
3M-8.8%-0.9%-7.8%-8.7%
6M-4.6%+11.9%-16.5%-5.6%
YTD+1.0%+24.0%-23.0%-1.0%
1Y+6.9%+27.0%-20.2%+4.5%
3Y+52.5%+26.3%+26.2%+47.2%
5Y+40.3%-70.9%+111.2%+51.3%
All+97.3%+139.1%-41.8%+77.2%

Cumulative growth

Daily Returns

Daily percentage return beside MTCH.

Daily Out/Under-Performance

Portfolio return minus MTCH return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MTCH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MTCH wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling